{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:55:10Z","timestamp":1792270510429,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110150","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T07:17:42Z","timestamp":1725607062000},"page":"110150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The neurobiology of antisocial personality disorder"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5290-2645","authenticated-orcid":false,"given":"Olivia","family":"Choy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Raine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110150_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40732-015-0139-y","article-title":"Effects of intranasal oxytocin on aggressive responding in antisocial personality disorder","volume":"65","author":"Alcorn","year":"2015","journal-title":"Psychol. Rec."},{"key":"10.1016\/j.neuropharm.2024.110150_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"10.1016\/j.neuropharm.2024.110150_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/YPG.0b013e3283437175","article-title":"Exploring epistasis in candidate genes for antisocial personality disorder","volume":"21","author":"Arias","year":"2011","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2024.110150_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psychres.2019.05.046","article-title":"Executive function, attention, and memory deficits in antisocial personality disorder and psychopathy","volume":"278","author":"Baliousis","year":"2019","journal-title":"Psychiatr. Res."},{"issue":"31","key":"10.1016\/j.neuropharm.2024.110150_bib6","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1523\/JNEUROSCI.1554-07.2007","article-title":"The role of the dorsal striatum in reward and decision-making","volume":"27","author":"Balleine","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2006.01.009","article-title":"Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder","volume":"169","author":"Barkataki","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/070674371105600605","article-title":"Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality dsorder: association with temperament and psychopathy","volume":"56","author":"Basoglu","year":"2011","journal-title":"Can. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.clinph.2020.02.031","article-title":"GRM8 genotype is associated with externalizing disorders and greater inter-trial variability in brain activation during a response inhibition task","volume":"131","author":"Bauer","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib10","doi-asserted-by":"crossref","DOI":"10.1037\/a0018074","article-title":"Child maltreatment moderates the association of MAOA with symptoms of depression and antisocial personality disorder","volume":"24","author":"Beach","year":"2010","journal-title":"J. Fam. Psychol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110150_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/070674371506000703","article-title":"The natural history of antisocial personality disorder","volume":"60","author":"Black","year":"2015","journal-title":"Can. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/713650607","article-title":"Neoteny, psychiatric disorders and the social brain: hypotheses on heterochrony and the modularity of the mind","volume":"7","author":"Br\u00fcne","year":"2000","journal-title":"Anthropol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brs.2011.03.002","article-title":"Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions","volume":"5","author":"Brunoni","year":"2012","journal-title":"Brain Stimul."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cpr.2008.12.004","article-title":"Are there meaningful etiological differences within antisocial behavior? Results of a meta-analysis","volume":"29","author":"Burt","year":"2009","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S0033291706009020","article-title":"The different origins of stability and change in antisocial personality disorder symptoms","volume":"37","author":"Burt","year":"2007","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2013.05.004","article-title":"MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction","volume":"75","author":"Byrd","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/life13051220","article-title":"Non-invasive brain stimulation for the modulation of aggressive behavior\u2014a systematic review of randomized sham-controlled studies","volume":"13","author":"Casula","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2010.03.021","article-title":"Morphological correlates of MAO A VNTR polymorphism: new evidence from cortical thickness measurement","volume":"211","author":"Cerasa","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110150_bib19","series-title":"The Routledge Handbook of the Philosophy and Science of Punishment","first-page":"215","article-title":"Biosocial risk factors for offending","author":"Choy","year":"2020"},{"key":"10.1016\/j.neuropharm.2024.110150_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpsychires.2022.03.006","article-title":"Larger striatal volume is associated with increased adult psychopathy","volume":"149","author":"Choy","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110150_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2021.05.016","article-title":"The modulatory role of serotonin on human impulsive aggression","volume":"90","author":"da Cunha-Bang","year":"2021","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41582-023-00920-0","article-title":"Forensic neurology: a distinct subspecialty at the intersection of neurology, neuroscience and law","volume":"20","author":"Darby","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065566","article-title":"Cool and hot executive function impairments in violent offenders with antisocial personality disorder with and without psychopathy","volume":"8","author":"De Brito","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110150_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neubiorev.2021.11.003","article-title":"Heart rate and skin conductance associations with physical aggression, psychopathy, antisocial personality disorder and conduct disorder: an updated meta-analysis","volume":"132","author":"De Looff","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/per.2207","article-title":"Untangling intelligence, psychopathy, antisocial personality disorder, and conduct problems: a meta-analytic review","volume":"33","author":"de Ribera","year":"2019","journal-title":"Eur. J. Pers."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/20438087231210477","article-title":"How do people with antisocial personality disorder with or without psychopathic personality disorder activate and regulate emotions? Neurovegetative responses during an autobiographical task","volume":"14","author":"Degouis","year":"2023","journal-title":"J. Exp. Psychopathol."},{"key":"10.1016\/j.neuropharm.2024.110150_bib27","series-title":"The Ashgate Research Companion to Biosocial Theories of Crime","first-page":"167","article-title":"The limbic system and crime","author":"DeLisi","year":"2016"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/0093854818765593","article-title":"Antisocial personality disorder with or without antecedent conduct disorder: the differences are psychiatric and paraphilic","volume":"45","author":"DeLisi","year":"2018","journal-title":"Crim. Justice Behav."},{"key":"10.1016\/j.neuropharm.2024.110150_bib29","first-page":"225","article-title":"Executive functions","volume":"vol. 173","author":"Diamond","year":"2020"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110150_bib30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1530-0277.2007.00470.x","article-title":"Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1","volume":"31","author":"Dick","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110150_bib31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1017\/S0033291711002686","article-title":"The neuropsychology of prefrontal function in antisocial personality disordered offenders with varying degrees of psychopathy","volume":"42","author":"Dolan","year":"2012","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4927(02)00085-9","article-title":"Quantitative frontal and temporal structural MRI studies in personality-disordered offenders and control subjects","volume":"116","author":"Dolan","year":"2002","journal-title":"Psychiatr. Res. Neuroimaging"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/YPG.0b013e3283457c15","article-title":"5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder","volume":"21","author":"Douglas","year":"2011","journal-title":"Psychiatr. Genet."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.mp.4002034","article-title":"Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women","volume":"13","author":"Ducci","year":"2008","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/ajmg.b.30666","article-title":"Externalizing disorders in American Indians: comorbidity and a genome wide linkage analysis","volume":"147B","author":"Ehlers","year":"2008","journal-title":"Am. J. Med. Genet. Part B-Neuropsychiatric Genetics"},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110150_bib36","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1177\/0306624X221139073","article-title":"Which clinical and demographic factors are related to incarceration in male patients with antisocial personality disorder?","volume":"67","author":"Esposito","year":"2023","journal-title":"Int. J. Offender Ther. Comp. Criminol."},{"issue":"9306","key":"10.1016\/j.neuropharm.2024.110150_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(02)07740-1","article-title":"Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys","volume":"359","author":"Fazel","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110150_bib38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.59.12.1125","article-title":"Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men","volume":"59","author":"Fu","year":"2002","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bandc.2011.06.010","article-title":"P3 event-related potentials and childhood maltreatment in successful and unsuccessful psychopaths","volume":"77","author":"Gao","year":"2011","journal-title":"Brain Cognit."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110150_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.psychres.2008.12.018","article-title":"Incremental effect for antisocial personality disorder genetic risk combining 5-HTTLPR and 5-HTTVNTR polymorphisms","volume":"177","author":"Garcia","year":"2010","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.110150_bib41","series-title":"Cognitive Neuroscience: the Biology of the Mind","author":"Gazzaniga","year":"2009"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.comppsych.2007.04.009","article-title":"DSM-IV conduct disorder criteria as predictors of antisocial personality disorder","volume":"48","author":"Gelhorn","year":"2007","journal-title":"Compr. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib43","first-page":"261","article-title":"Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits","volume":"18","author":"Gerra","year":"2003","journal-title":"International Cinical Psychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110150_bib44","article-title":"Psychological interventions for antisocial personality disorder","author":"Gibbon","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.avb.2011.03.009","article-title":"Evolutionary theory and psychopathy","volume":"16","author":"Glenn","year":"2011","journal-title":"Aggress. Violent Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4088\/JCP.15m10358","article-title":"The epidemiology of antisocial behavioral syndromes in adulthood: results from the national epidemiologic survey on alcohol and related conditions-III","volume":"78","author":"Goldstein","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110150_bib47","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archgenpsychiatry.2012.222","article-title":"The antisocial brain: psychopathy matters: a Structural MRI investigation of antisocial male violent offenders","volume":"69","author":"Gregory","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03033482","article-title":"Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3\u2032 region of the DRD2 gene","volume":"11","author":"Hoenicka","year":"2007","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1037\/0021-843X.110.3.423","article-title":"Autonomic stress reactivity and executive functions in successful and unsuccessful criminal psychopaths from the community","volume":"110","author":"Ishikawa","year":"2001","journal-title":"J. Abnorm. Psychol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41386-023-01549-9","article-title":"Oxytocin effects on amygdala reactivity to angry faces in males and females with antisocial personality disorder","volume":"48","author":"Jeung-Maarse","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110150_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2016.08.052","article-title":"Reduced cortical thickness and increased surface area in antisocial personality disorder","volume":"337","author":"Jiang","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110150_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jocn.2020.01.048","article-title":"Reduced hippocampus and amygdala volumes in antisocial personality disorder","volume":"75","author":"Kaya","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110150_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/PGPM.S23462","article-title":"Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy","author":"Kenna","year":"2012","journal-title":"Pharmacogenomics Personalized Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110150_bib55","article-title":"Pharmacological interventions for antisocial personality disorder","author":"Khalifa","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110150_bib56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.mp.4001851","article-title":"MAOA, maltreatment, and gene\u2013environment interaction predicting children's mental health: new evidence and a meta-analysis","volume":"11","author":"Kim-Cohen","year":"2006","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/brainsci12020200","article-title":"Modulating Behavioural and self-reported aggression with non-invasive brain stimulation: a literature review","volume":"12","author":"Knehans","year":"2022","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110150_bib58","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ijnp\/pyy035","article-title":"Corticostriatal connectivity in antisocial personality disorder by MAO-A genotype and its relationship to aggressive behavior","volume":"21","author":"Kolla","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1011-6","article-title":"Single-photon emission computed tomography and positron emission tomography studies of antisocial personality disorder and Aggression: a targeted review","volume":"21","author":"Kolla","year":"2019","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.neuropharm.2024.110150_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08351-w","article-title":"Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits","volume":"7","author":"Kolla","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0004867413512690","article-title":"Lower anterior cingulate volume in seriously violent men with antisocial personality disorder or schizophrenia and a history of childhood abuse","volume":"48","author":"Kumari","year":"2014","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4927(02)00005-7","article-title":"Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism","volume":"114","author":"Laakso","year":"2002","journal-title":"Psychiatr. Res. Neuroimaging"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0166-4328(99)00172-2","article-title":"A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism","volume":"109","author":"Laakso","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40865-023-00239-w","article-title":"Impact of family violence on antisocial behaviors in two developmental periods: the investigation of the moderating role of a haplotypic serotonergic polygenic score","volume":"9","author":"Langevin","year":"2023","journal-title":"Journal of Developmental and Life-Course Criminology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110150_bib65","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biopsych.2011.12.011","article-title":"Association of COL25A1 with comorbid antisocial personality disorder and substance dependence","volume":"71","author":"Li","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/YPG.0000000000000352","article-title":"Genome-wide association study of antisocial personality disorder diagnostic criteria provides evidence for shared risk factors across disorders","volume":"33","author":"Li","year":"2023","journal-title":"Psychiatr. Genet."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000080953","article-title":"Possible association between serotonin transporter promoter region polymorphism and extremely violent crime in Chinese males","volume":"50","author":"Liao","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib68","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/1068316X.2019.1572753","article-title":"Biological explanations of criminal behavior","volume":"25","author":"Ling","year":"2019","journal-title":"Psychol. Crime Law"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S0033291708005102","article-title":"Effects of induced anger in patients with antisocial personality disorder","volume":"39","author":"Lobbestael","year":"2009","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/YPG.0b013e3281ac237e","article-title":"Serotonin transporter polymorphism and borderline or antisocial traits among low-income young adults","volume":"17","author":"Lyons-Ruth","year":"2007","journal-title":"Psychiatr. Genet."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110150_bib71","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1037\/a0032247","article-title":"Sexual selection and sex differences in the prevalence of childhood externalizing and adolescent internalizing disorders","volume":"139","author":"Martel","year":"2013","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2024.110150_bib72","series-title":"The Maladapted Mind","first-page":"133","article-title":"The sociobiology of sociopathy: an integrated evolutionary model","author":"Mealey","year":"2013"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mehy.2005.05.027","article-title":"Etiology of antisocial personality disorder: benefits for society from an evolutionary standpoint","volume":"65","author":"Miric","year":"2005","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/cogp.1999.0734","article-title":"The unity and diversity of executive functions and their contributions to complex \u201cfrontal lobe\u201d tasks: a latent variable analysis","volume":"41","author":"Miyake","year":"2000","journal-title":"Cognit. Psychol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib75","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/schbul\/sbj068","article-title":"Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders","volume":"32","author":"Mueser","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12882","article-title":"Increased burden of rare protein\u2010truncating variants in constrained, brain\u2010specific and synaptic genes in extremely impulsively violent males with antisocial personality disorder","volume":"23","author":"Mu\u0161\u00e1lkov\u00e1","year":"2024","journal-title":"Gene Brain Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110150_bib77","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1176\/appi.ajp.2007.06101631","article-title":"Regional cortical thinning in subjects with violent antisocial personality disorder or schizophrenia","volume":"164","author":"Narayan","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110150_bib78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3758\/s13415-011-0083-5","article-title":"Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions","volume":"12","author":"Niendam","year":"2012","journal-title":"Cognit. Affect Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1745-9125.2011.00252.x","article-title":"Neuropsychological measures of executive function and antisocial behavior: a meta\u2010analysis","volume":"49","author":"Ogilvie","year":"2011","journal-title":"Criminology"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib80","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/15228932.2010.481234","article-title":"Biological and environmental correlates of aggressive behavior","volume":"10","author":"Palermo","year":"2010","journal-title":"J. Forensic Psychol. Pract."},{"key":"10.1016\/j.neuropharm.2024.110150_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2015.12.003","article-title":"Modulatory effects of psychopathy on Wisconsin card sorting test performance in male offenders with antisocial personality disorder","volume":"235","author":"Pera-Guardiola","year":"2016","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.110150_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.avb.2015.02.004","article-title":"Resting heart rate and antisocial behavior: an updated systematic review and meta-analysis","volume":"22","author":"Portnoy","year":"2015","journal-title":"Aggress. Violent Behav."},{"key":"10.1016\/j.neuropharm.2024.110150_bib83","series-title":"The Psychopathology of Crime: Criminal Behavior as a Clinical Disorder","author":"Raine","year":"1993"},{"key":"10.1016\/j.neuropharm.2024.110150_bib84","series-title":"The Anatomy of Violence: the Biological Roots of Crime","author":"Raine","year":"2013"},{"issue":"14","key":"10.1016\/j.neuropharm.2024.110150_bib85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-clinpsy-050817-084819","article-title":"Antisocial personality as a neurodevelopmental disorder","volume":"14","author":"Raine","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2024.110150_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.avb.2024.101956","article-title":"Omega-3 supplementation reduces aggressive behavior: a meta-analytic review of randomized controlled trials","author":"Raine","year":"2024","journal-title":"Aggress. Violent Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.57.2.119","article-title":"Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder","volume":"57","author":"Raine","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib88","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/mp.2009.136","article-title":"Sex differences in orbitofrontal gray as a partial explanation for sex differences in antisocial personality","volume":"16","author":"Raine","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110150_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.155","article-title":"Genome-wide association study of antisocial personality disorder","volume":"6","author":"Rautiainen","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"14","key":"10.1016\/j.neuropharm.2024.110150_bib90","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1017\/S0033291715001117","article-title":"A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood","volume":"45","author":"Reichborn-Kjennerud","year":"2015","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11033-021-06137-y","article-title":"The effects of 5-HTTLPR\/rs25531 serotonin transporter gene polymorphisms on antisocial personality disorder among criminals in a sample of the Turkish population","volume":"48","author":"Sah","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17512433.2023.2181159","article-title":"Pharmacological strategies for the management of the antisocial personality disorder","volume":"16","author":"Sesso","year":"2023","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib93","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cortex.2011.06.005","article-title":"White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder","volume":"48","author":"Sundram","year":"2012","journal-title":"Cortex"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110150_bib94","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jclp.23504","article-title":"Societal costs of personality disorders: a cross\u2010sectional multicenter study of treatment\u2010seeking patients in mental health services in Norway","volume":"79","author":"Sveen","year":"2023","journal-title":"J. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060652","article-title":"Identifying individuals with antisocial personality disorder using resting-state FMRI","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110150_bib96","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pscychresns.2007.08.012","article-title":"Brain anatomy of persistent violent offenders: more rather than less","volume":"163","author":"Tiihonen","year":"2008","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2024.110150_bib98","article-title":"Impaired striatal glutamate\/GABA regulation in violent offenders with antisocial personality disorder and psychopathy","volume":"1\u20139","author":"Tully","year":"2024","journal-title":"Mol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110150_bib99","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/1096-8628(20001009)96:5<654::AID-AJMG11>3.0.CO;2-Y","article-title":"Antisociality, substance dependence, and the DRD5 gene: a preliminary study","volume":"96","author":"Vanyukov","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/scan\/nsaa158","article-title":"Consequences of prefrontal tDCS on inhibitory control and reactive aggression","volume":"17","author":"Weidler","year":"2022","journal-title":"Soc. Cognit. Affect Neurosci."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110150_bib101","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s40265-020-01372-2","article-title":"Pharmacological approaches to managing violence and aggression in prison populations: clinical and ethical issues","volume":"80","author":"Weightman","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3928\/00485713-20150401-08","article-title":"Epidemiology, comorbidity, and behavioral genetics of antisocial personality disorder and psychopathy","volume":"45","author":"Werner","year":"2015","journal-title":"Psychiatr. Ann."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/14999013.2014.890682","article-title":"Can antisocial personality disorder be treated? A meta-analysis examining the effectiveness of treatment in reducing recidivism for individuals diagnosed with ASPD","volume":"13","author":"Wilson","year":"2014","journal-title":"Int. J. Forensic Ment. Health"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110150_bib104","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pnpbp.2011.11.009","article-title":"The association of 5-HTR2A-1438A\/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects","volume":"36","author":"Yang","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110150_bib105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2005.09.013","article-title":"Essential fatty acids and the brain: from infancy to aging","volume":"26","author":"Yehuda","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110150_bib106","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1750-8606.2012.00246.x","article-title":"Hot and cool executive function in childhood and adolescence: development and plasticity","volume":"6","author":"Zelazo","year":"2012","journal-title":"Child Development Perspectives"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T22:57:09Z","timestamp":1730847429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":105,"alternative-id":["S0028390824003198"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110150","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurobiology of antisocial personality disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110150"}}